The central feature of patent law in the chemical, biotechnology, and pharmaceutical
industries is the genus claim-a patent claim that covers not just one specific chemical but a …

In May of 2005, a team of scientists made headlines after the prestigious journal Science
published a report that they had cloned human embryos.'Only a few months later, the team …

Pharmaceutical companies often replace prescription drugs that are already on the market
with modified versions that have the same active pharmaceutical ingredient. On the surface …

Patents and trade secrets are often considered economic substitutes. Under this view,
inventors can decide either to maintain an invention as a trade secret or to seek a patent and …

Findings at the frontier of economics suggest startling implications of an under-appreciated
fact about technological development: innovation builds on itself developing path …

In four cases over five recent Terms, the Supreme Court has struggled to place coherent
limits on what kinds of inventions can be rewarded through the patent system. 1 This effort to …

Patent law-and in particular the law governing patent eligibility-is in a state of crisis. This
crisis is one of profound confusion. Confusion exists because the current approach to …

Clinical research faces a reproducibility crisis. Many recent clinical and preclinical studies
appear to be irreproducible-their results cannot be verified by outside researchers. This is …

The requirement of nonobviousness, codified in 35 USC § 103, has been called" the
ultimate condition of patentability" because of its crucial function of keeping technically trivial …

A researcher may patent her novel invention once she" possesses" it. 1 Yet the question of
what constitutes possession has bedeviled property theorists for centuries, as demonstrated …